Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.790 | 0.160 | 3 | 50341515 | intron variant | A/G | snv | 0.22 | 0.20 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.790 | 0.160 | 3 | 50341515 | intron variant | A/G | snv | 0.22 | 0.20 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.790 | 0.160 | 3 | 50341515 | intron variant | A/G | snv | 0.22 | 0.20 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.790 | 0.160 | 3 | 50341515 | intron variant | A/G | snv | 0.22 | 0.20 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.790 | 0.160 | 3 | 50341515 | intron variant | A/G | snv | 0.22 | 0.20 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.790 | 0.160 | 3 | 50341515 | intron variant | A/G | snv | 0.22 | 0.20 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Skin and Connective Tissue Diseases; Immune System Diseases; Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
|
0.882 | 0.040 | 3 | 50334001 | intron variant | C/A | snv | 0.39 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.040 | 3 | 50334001 | intron variant | C/A | snv | 0.39 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.040 | 3 | 50334001 | intron variant | C/A | snv | 0.39 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.120 | 3 | 50331718 | missense variant | G/A | snv | 8.0E-06 | 1.4E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.010 | < 0.001 | 1 | 2004 | 2004 | ||||||
|
1.000 | 0.120 | 3 | 50331652 | missense variant | G/A | snv | 4.0E-06 | 4.2E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.010 | < 0.001 | 1 | 2004 | 2004 |